Alyson Fox, MD, MSCE
Expertise:
About:
Dr. Alyson Fox earned her BA in Public Health at the Johns Hopkins University prior to attending the Mount Sinai School of Medicine. She completed her residency in Internal Medicine at NewYork-Presbyterian Weill Cornell Medical Center, where she served as assistant chief resident. She completed her Gastroenterology fellowship at the University of Pennsylvania. While at Penn, she completed a Masters in Clinical Epidemiology and served as chief fellow. She completed her advanced fellowship training in Advanced Transplant Hepatology at the University of California, San Francisco and was named clinical fellow of the year by the Department of Medicine.
Dr. Fox's clinical practice is focused on the management of patients with a variety of liver diseases including viral hepatitis, alcoholic and non-alcoholic fatty liver diseases, inherited and autoimmune liver diseases and liver cancers. As a transplant hepatologist, she has advanced training in the management of the complications of end stage liver disease and caring for patients both pre- and post- liver transplantation.
As the medical director of the adult transplant program, she oversees the program operations, protocols, outcomes and initiatives. When she is not caring for patients, she is active as a course director and educator at the Columbia University Vagelos College of Physicians and Surgeons.
Visit The Center for Liver Disease and Transplantation at columbiasurgery.org/liver
Interests:
Publications:
Original, Peer Reviewed ArticlesFox AN, Liapakis A, Batra R, Bittermann T, Emamaullee J, Emre S, Genyk Y, Han H, Jackson W, Pomfret E, Raza M, Rodriguez-Davalos M, Rubman Gold S, Samstein B, Shenoy A, Taner T, Roberts JP; North American Living Liver Donor Innovations Group (NALLDIG). The use of nondirected donor organs in living donor liver transplantation: Perspectives and guidance.Hepatology. 2021 Dec 3. doi: 10.1002/hep.32260. Online ahead of print.
Rosenblatt R, Wahid N, Halazun KJ, Kaplan A, Jesudian A, Lucero C, Lee J, Dove L, Fox A, Verna E, Samstein B, Fortune BE, Brown RS Jr. Black Patients Have Unequal Access to Listing for Liver Transplantation in the United States. Hepatology. 2021 Mar 29. doi: 10.1002/hep.31837. Online ahead of print.
Pereira MR, Aversa MM, Farr MA, Miko BA, Aaron JG, Mohan S, Cohen DJ, Husain SA, Ratner LE, Arcasoy S, Uriel N, Zheng EX, Fox AN, Tsapepas DS, Emond JC, Verna EC. Tocilizumab for severe COVID-19 in solid organ transplant recipients: a matched cohort study. Am J Transplant. 2020 Nov;20(11):3198-3205.
Phipps MM, Barraza LH, LaSota ED, Sobieszczyk ME, Pereira MR, Zheng EX,Fox AN, Zucker J, Verna EC. Acute Liver Injury in COVID-19: Prevalence and Association with Clinical Outcomes in a Large US Cohort.Hepatology. 2020 May 30.
Lawrence ZE, Martinez M, Lobritto S, Chen J, Breslin N, Fox A, Vittorio J. Adherence, Medical Outcomes, and Health Care Costs in Adolescents/Young Adults Following Pediatric Liver Transplantation. J Pediatr Gastroenterol Nutr. 2019 Nov.
Al-Obaid LN, Bazarbashi AN, Cohen ME, Kim J, Lei Y, Axelrad JE,Fox A, Chandra S, GordonFD. Enteric tube placement in patients with esophageal varices: Risks and predictors of postinsertion gastrointestinal bleeding.JGH Open. 2019 Sep 10;4(2):256-259.
Kawut SM, Ellenberg SS, Kowka MJ, Goldberg D, Vargas H, Koch D, Sharkowski T, Al-Naamani, Fox A, Brown R, Levitsky J. Oh JK, Lin G, Song N, Mottram C, Doyle MF, Kaplan DE, Gupta S, Fallon MB. Sorafenib in Hepatopulmonary Syndrome (SHPS): A Randomized, Double-Blind Placebo-Controlled Trial. Liver Transpl. 2019 Aug;25(8):1155-1164
Przybyszewski EM, Verna EC, Lobritto SJ, Martinez M, Vittorio JM, Fox AN, Samstein B, KatoT, Griesemer AD, Emond JC. Durable Clinical and ImmunolgicAdvantage of Living Donor Liver Transplantation in Children. Transplantation 2018 June;102(6):953-60
Dew MA, Butt Z, Liu Q, Simpson MA, Zee J, Ladner DP, Holtzman S, Smith AR, Pomfret EA, Merion RM, Gillespie BW, Sherker AH, Fisher RA, Olthoff KM, BurtonJR Jr, Terrault NA, Fox AN, DiMartini AF. Prevalence and Predictors of Patient-Reported Long-Term Mental and Physical Health After Donation in the Adult to Adult Living Donor Liver Transplantation Cohort Study (A2ALL).Transplantation. 2017 Sep 6.
Samstein B, Griesemer A, Cherqui D, Mansour T, Pisa J, Yegiants A, Fox AN, Guarrera JV, Kato T, Halazun KJ, Emond J. Fully laparoscopic left-sided donor hepatectomy is safe and associated with shorter hospital stay and earlier return to work: A comparative study. Liver Transpl. 2015 Jun; 21(6):768-73
Verna EC, Shetty K, Lukose T, Terry N, Mentore K, Olsen SK, Fox AN, Dove LM, Brown RS. High post-transplant virological response in hepatitis C virus infected patients treated with pretransplant protease inhibitor-based triple therapy.Liver Int. 2015 Feb; 35(2):510-517
Kluger MD, Halazun KJ, Barroso RT, Fox AN, Olsen SK, Madoff DC, Siegel AB, Weintraub JL, Sussman J, Brown RS Jr, Cherqui D, Emond JC. Bland embolization versus chemoembolization of hepatocellular carcinoma before transplantation.Liver Transpl. 2014 May;20(5):536-43
Lee SY, Mooney MA, Inra ML, Juluru K, Fox AN, Olsen SK, Brown RS Jr, Emond JC, Cherqui D, Kluger M. Exposure to ionizing radiation during liver transplantation evaluation, waitlist time, and post-operative period: A cause for concern. Hepatology. 2014 Feb; 59(2): 496-504
Cascino MD, McNabb B, Gardner DG, Woeber KA, Fox AN, Wang B, Fix OK. Acute Liver Failure with Thyrotoxicosis treated with liver transplantation. Endocr Prac, 2013 May-Jun; 19(3):357-60
Fox AN, Schilsky M. Once Daily Trientine for Maintenance Therapy of Wilson Disease. American Journal of Gastroenterology. Feb 2008;103(2):494-5.